Labat Africa starts recruitment for its first cannabis trial
Study will involve participants taking opioids for pain management who are willing to switch to cannabis
21 June 2022 - 18:54
Labat Africa, an investment company looking to take advantage of rising demand for cannabis-derived products, has started recruiting people for its first clinical cannabis trial in SA.
Labat’s East London research subsidiary Biodata will run the Pharma Ethics Observational Study in order to test whether cannabis can replace opioids for managing chronic pain, the company said in a statement on Tuesday...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.